Sun Pharmaceutical Industries Limited (BOM:524715)
1,788.90
+41.65 (2.38%)
At close: Apr 23, 2025
BOM:524715 Revenue
Sun Pharmaceutical Industries had revenue of 136.75B INR in the quarter ending December 31, 2024, with 10.46% growth. This brings the company's revenue in the last twelve months to 516.03B, up 8.76% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharmaceutical Industries had annual revenue of 484.97B with 10.51% growth.
Revenue (ttm)
516.03B
Revenue Growth
+8.76%
P/S Ratio
8.32
Revenue / Employee
12.00M
Employees
43,000
Market Cap
4,291.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
Mar 31, 2020 | 328.38B | 37.72B | 12.98% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,398.38B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,409.52B |
Infosys | 1,647.16B |
Bajaj Finance | 358.05B |
Sun Pharmaceutical Industries News
- 7 days ago - Nifty 50 top gainers today, April 17: Eternal, Sun Pharmaceutical, ICICI Bank, Bharti Airtel and more - Business Upturn
- 10 days ago - Glenmark, Sun & Zydus recall products in US for 'manufacturing deviations' - The Times of India
- 13 days ago - Sun Pharma shares jump over 4% after US court clears LEQSELVI™ launch - Business Upturn
- 14 days ago - Sun Pharma cleared to launch LEQSELVI™ in U.S. as court vacates injunction - Business Upturn
- 15 days ago - Indian pharma stocks tumble as Trump signals tariffs on drug imports - The Times of India
- 15 days ago - Pharma Stocks Falls: Aurobindo Pharma slips 2%, Lupin down 2%, Divi’s Labs falls 3% as Trump reiterates tariffs on pharmaceuticals ‘soon’ - Business Upturn
- 17 days ago - Sun Pharma launches FEXUCLUE 40 mg in India for treatment of Erosive Esophagitis - Business Upturn
- 20 days ago - Sun Pharma shares fall over 4% today as tariff concerns resurface for pharma sector - Business Upturn